Cognitive and Perceptual Factors, Not Disease Severity, Are Linked with Anxiety in COPD: Results from a Cross-Sectional Study

Overview

Journal Int J Behav Med

Publisher Informa Healthcare

Date 2017 Aug 6

PMID 28779469

Citations 8

Authors

Elyse R Thakur

Shubhada Sansgiry

Nancy J Petersen

Melinda Stanley

Mark E Kunik

Aanand D Naik

Jeffrey A Cully

Affiliations

Soon will be listed here.

Abstract

Purpose: Guided by the Transactional Model of Stress and Coping, the purpose of this cross-sectional study was to examine clinical factors-demographics, chronic obstructive pulmonary disease (COPD) severity, cognitive/perceptual variables (appraisal and coping)-and their relationship to clinically elevated symptoms of anxiety in a sample of veterans with COPD.

Method: Participants included a sample of veterans with COPD, with or without comorbid congestive heart failure, and clinically significant symptoms of anxiety (n = 172, mean age = 65.3, SD = 8.1), who previously presented to an outpatient VA setting. Participants completed questionnaires examining COPD severity (respiratory impairment and dyspnea- and fatigue-related quality of life); perceptions of a stressor (COPD illness intrusiveness); perceptions of control (locus of health control, mastery over COPD, self-efficacy); coping strategies (adaptive and maladaptive); and anxiety and depressive symptoms.

Results: Multivariable linear regressions revealed that anxiety was positively associated with more maladaptive coping and locus of control (attributed to other people), above and beyond disease severity, demographics, and depressive symptoms.

Conclusion: These findings suggest that cognitive and perceptual factors are concurrent with anxiety; however, longitudinal investigations are needed to fully understand this relationship. Future research should also focus on identifying optimal assessment and treatment procedures when evaluating and treating patients with COPD and symptoms of anxiety.

Trial Registration: NCT01149772.

Citing Articles

Changes in COPD-related anxiety symptoms during pulmonary rehabilitation: a prospective quantitative and qualitative study.

Farver-Vestergaard I, Buksted E, Sorensen D, Jonstrup S, Hansen H, Christiansen C Front Rehabil Sci. 2024; 5:1428893.

PMID: 39169921 PMC: 11335722. DOI: 10.3389/fresc.2024.1428893.

Illness Intrusiveness in Adults with Sickle Cell Disease: The Role of Fatigue.

McGill L, Hughes A, Carroll C, Bediako S J Clin Psychol Med Settings. 2023; 30(4):866-875.

PMID: 36881316 DOI: 10.1007/s10880-023-09950-8.

Substance Use and Misuse among Adults with Chronic Obstructive Pulmonary Disease in the United States, 2015-2019: Prevalence, Association, and Moderation.

Alanazi A, Alqahtani M, Alquaimi M, Alotaibi T, Algarni S, Ismaeil T Int J Environ Res Public Health. 2022; 19(1).

PMID: 35010669 PMC: 8744618. DOI: 10.3390/ijerph19010408.

Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review.

Williams M, Johnston K, Paquet C Int J Chron Obstruct Pulmon Dis. 2020; 15:903-919.

PMID: 32425516 PMC: 7186773. DOI: 10.2147/COPD.S178049.

The meaning of the name of 'pulmonary rehabilitation' and its influence on engagement with individuals with chronic lung disease.

Oxley R, Harrison S, Rose A, Macnaughton J Chron Respir Dis. 2019; 16:1479973119847659.

PMID: 31137961 PMC: 6539565. DOI: 10.1177/1479973119847659.

References

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

Simpson E, Jones M . An exploration of self-efficacy and self-management in COPD patients. Br J Nurs. 2013; 22(19):1105-9. DOI: 10.12968/bjon.2013.22.19.1105. View

Edwards R, Telfair J, Cecil H, Lenoci J . Self-efficacy as a predictor of adult adjustment to sickle cell disease: one-year outcomes. Psychosom Med. 2001; 63(5):850-8. DOI: 10.1097/00006842-200109000-00020. View

Breland J, Hundt N, Barrera T, Mignogna J, Petersen N, Stanley M . Identification of Anxiety Symptom Clusters in Patients with COPD: Implications for Assessment and Treatment. Int J Behav Med. 2015; 22(5):590-6. DOI: 10.1007/s12529-014-9450-2. View

Stoilkova A, Janssen D, Franssen F, Spruit M, Wouters E . Coping styles in patients with COPD before and after pulmonary rehabilitation. Respir Med. 2013; 107(6):825-33. DOI: 10.1016/j.rmed.2013.03.001. View

Usmani Z, Carson K, Cheng J, Esterman A, Smith B . Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011; (11):CD008483. DOI: 10.1002/14651858.CD008483.pub2. View

De Peuter S, Janssens T, Van Diest I, Stans L, Troosters T, Decramer M . Dyspnea-related anxiety: The Dutch version of the Breathlessness Beliefs Questionnaire. Chron Respir Dis. 2010; 8(1):11-9. DOI: 10.1177/1479972310383592. View

van Ede L, Yzermans C, Brouwer H . Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999; 54(8):688-92. PMC: 1745552. DOI: 10.1136/thx.54.8.688. View

Hundt N, Amspoker A, Kraus-Schuman C, Cully J, Rhoades H, Kunik M . Predictors of CBT outcome in older adults with GAD. J Anxiety Disord. 2014; 28(8):845-50. PMC: 4254548. DOI: 10.1016/j.janxdis.2014.09.012. View

10.

Yellowlees P, Alpers J, Bowden J, BRYANT G, Ruffin R . Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust. 1987; 146(6):305-7. DOI: 10.5694/j.1326-5377.1987.tb120267.x. View

11.

Barrera T, Cully J, Amspoker A, Wilson N, Kraus-Schuman C, Wagener P . Cognitive-behavioral therapy for late-life anxiety: Similarities and differences between Veteran and community participants. J Anxiety Disord. 2015; 33:72-80. PMC: 4479977. DOI: 10.1016/j.janxdis.2015.04.005. View

12.

Guyatt G, BERMAN L, Townsend M, Pugsley S, Chambers L . A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987; 42(10):773-8. PMC: 460950. DOI: 10.1136/thx.42.10.773. View

13.

Meek P, Lareau S . Critical outcomes in pulmonary rehabilitation: assessment and evaluation of dyspnea and fatigue. J Rehabil Res Dev. 2004; 40(5 Suppl 2):13-24. DOI: 10.1682/jrrd.2003.10.0013. View

14.

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik M, Yohannes A . Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134(4 Suppl):43S-56S. PMC: 2849676. DOI: 10.1378/chest.08-0342. View

15.

Keil D, Stenzel N, Kuhl K, Vaske I, Mewes R, Rief W . The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis. 2014; 11(1):31-40. DOI: 10.1177/1479972313516881. View

16.

Carver C . You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997; 4(1):92-100. DOI: 10.1207/s15327558ijbm0401_6. View

17.

Scharloo M, Kaptein A, Weinman J, Willems L, Rooijmans H . Physical and psychological correlates of functioning in patients with chronic obstructive pulmonary disease. J Asthma. 2000; 37(1):17-29. DOI: 10.3109/02770900009055425. View

18.

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

19.

Paukert A, LeMaire A, Cully J . Predictors of depressive symptoms in older veterans with heart failure. Aging Ment Health. 2009; 13(4):601-10. DOI: 10.1080/13607860802459823. View

20.

Aydin I, Ulusahin A . Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry. 2001; 23(2):77-83. DOI: 10.1016/s0163-8343(01)00116-5. View